Toripalimab trials for Breast cancer

All Toripalimab trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Toripalimab for Breast cancer

• A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer
  NCT07540533 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.
  NCT06371274 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer
  NCT06178159 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety Study of Disitamab Vedotin + RC148 vs. Albumin-Paclitaxone ± Toripalimab in HR-/HER2-low Breast Cancer
  NCT06642545 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer
  NCT06387628 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer
  NCT06964906 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
  NCT06914440 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• The Optimal Radioimmunotherapy Combinations for Advanced TNBC
  NCT06735131 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer
  NCT06389006 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Toripalimab for Breast cancer?

9 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.